Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies

References

• Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–238.
   PubMed Web of Science ®Google Scholar
• Canbay A, Kachru N, Haas JS, et al. Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. Ann Transl Med. 2021;9(8):615.
   PubMed Web of Science ®Google Scholar
• Khan ZA, Khan MU, Brand M. Increases in cholecystectomy for gallstone related disease in South Africa. Sci Rep. 2020;10(1):13516.
   PubMed Web of Science ®Google Scholar
• Su PY, Hsu YC, Cheng YF, et al. Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years. BMC Gastroenterol. 2019;19(1):117.
   PubMedGoogle Scholar
• Zhang JW, Xiong JP, Xu WY, et al. Fruits and vegetables consumption and the risk of gallstone diasease: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(28):e16404.
   PubMed Web of Science ®Google Scholar
• Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. 2017;37(Suppl 1):81–84.
   PubMedGoogle Scholar
• Lin J, Shao WQ, Chen QZ, et al. Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1. Mol Med Rep. 2017;16(2):1785–1792.
   PubMed Web of Science ®Google Scholar
• Nervi F, Cholecystectomy AM. NAFLD: does gallbladder removal have metabolic consequences? Am J Gastroenterol. 2013;108(6):959–961.
   PubMed Web of Science ®Google Scholar
• Huang RX, Wang BC, Fan JG. Research advances of relationship between non-alcoholic fatty liver disease and biliary tract diseases. Zhonghua Gan Zang Bing Za Zhi. 2017;25(8):633–636.
   PubMedGoogle Scholar
• Li X, Guo X, Ji H, et al. Gallstones in patients with chronic liver diseases. Biomed Res Int. 2017;2017:9749802.
   PubMed Web of Science ®Google Scholar
• Chang Y, Noh YH, Suh BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: a cohort study. J Clin Med. 2018;7(11):458.
   PubMed Web of Science ®Google Scholar
• Liu J, Lin H, Zhang C, et al. Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population. BMC Gastroenterol. 2014;14(1):213.
   PubMedGoogle Scholar
• Khaw KB, Choi RH, Kam JH, et al. Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population. Singapore Med J. 2017;58(12):703–707.
   PubMed Web of Science ®Google Scholar
• Kwak MS, Kim D, Chung GE, et al. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. World J Gastroenterol. 2015;21(20):6287–6295.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Ayyildiz T, Akin H, et al. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. Gut Liver. 2014;8(3):313–317.
   PubMed Web of Science ®Google Scholar
• Gao Y, Shan QS, Zhang YJ, et al. Cholecystectomy is a risk factor for fatty liver disease. J Hepatol. 2015;62:S754.
   Web of Science ®Google Scholar
• Shen SS, Gong JJ, Wang XW, et al. Promotional effect of nonalcoholic fatty liver disease on gallstone disease: a systematic review and meta-analysis. Turk J Gastroenterol. 2017;28(1):31–39.
   PubMed Web of Science ®Google Scholar
• Qin JJ, Ding WJ. Nonalcoholic fatty liver disease and its relevant factors increased the risk of gallstone disease: a systematic review and meta-analysis. INT J Clin Exp Med. 2016;9(2):3009–3016.
   Web of Science ®Google Scholar
• Jaruvongvanich V, Sanguankeo A, Upala S. Significant association between gallstone disease and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Digrst Dis Sci. 2016;61(8):2389–2396.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the us population. Am J Gastroenterol. 2013;108(6):952–958.
   PubMed Web of Science ®Google Scholar
• Méndez-Sánchez N, Valencia-Rodríguez A, Reyes EC, et al. Long-standing cholecystectomy as a risk factor for advanced fibrosis in patients with non-alcoholic fatty liver disease: an observational multicenter study. Hepatol. 2020;72(1 SUPPL):256A.
   Google Scholar
• Latenstein CSS, Alferink LJM, Darwish Murad S, et al. The association between cholecystectomy, metabolic syndrome, and nonalcoholic fatty liver disease: a population-based study. Clin Transl Gastroenterol. 2020;11(4):e00170.
   PubMedGoogle Scholar
• Garruti G, Wang DQ, Di Ciaula A, et al. Cholecystectomy: a way forward and back to metabolic syndrome? Lab Invest. 2018;98(1):4–6.
   PubMed Web of Science ®Google Scholar
• Acalovschi M. NAFLD, cholesterol gallstones and cholecystectomy. J Gastrointest Liver. 2018;27:21–22.
   Google Scholar
• Krolevets T, Cherkashchenko N, Livzan M. The role of adipokines in gallstone disease in patients with non-alcoholic fatty liver disease. Turk J Gastroenterol. 2019;30:S232–S233.
   Google Scholar
• Cortés V, Quezada N, Uribe S, et al. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. Lipids Health Dis. 2017;16(1):129.
   PubMedGoogle Scholar
• Cortés VA, Barrera F, Nervi F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity. Obes Rev. 2020;21(4):e12983.
   PubMed Web of Science ®Google Scholar
• Jaruvongvanich V, Sanguankeo A, Jaruvongvanich S, et al. Association between cholecystectomy and nonalcoholic fatty liver disease: a meta-analysis. World J Surg. 2016;40(11):2816–2817.
   PubMed Web of Science ®Google Scholar
• Negi CK, Babica P, Bajard L, et al. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. Metabolism. 2022;126:154925.
   PubMed Web of Science ®Google Scholar
• Tiderington E, Lee SP, Ko CW. Gallstones: new insights into an old story. F1000Res. 2016;5:F1000 Faculty Rev- 1817.
   PubMedGoogle Scholar
• Xie AJ, Mai CT, Zhu YZ, et al. Bile acids as regulatory molecules and potential targets in metabolic diseases. Life Sci. 2021;287:120152.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the study of liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107(6):811–826.
   PubMed Web of Science ®Google Scholar
• Lee YC, Wu JS, Yang YC, et al. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scand J Gastroenterol. 2014;49(8):1001–1006.
   PubMed Web of Science ®Google Scholar
• Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol. 2014;6:359–368.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Arrese M, Cortés V, Barrera F, et al. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship. Curr Opin Gastroenterol. 2018;34(2):90–96.
   PubMed Web of Science ®Google Scholar
• Lee JY, Moon JH, Park JS, et al. Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. Diabetes Metab J. 2011;35(5):489–496.
   PubMedGoogle Scholar
• Fang YL, Chen H, Wang CL, et al. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from “two hit theory” to “multiple hit model.” World J Gastroenterol. 2018;24(27):2974–2983.
   PubMed Web of Science ®Google Scholar
• Wei J, Qiu DK, Ma X. Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. J Dig Dis. 2009;10(2):85–90.
   PubMed Web of Science ®Google Scholar
• Corradini SG, Ferri F, Mordenti M, et al. Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control. World J Gastroenterol. 2012;18(9):930–937.
   PubMed Web of Science ®Google Scholar
• Farooqui N, Elhence A, Shalimar A. Current understanding of bile acids in chronic liver disease. J Clin Exp Hepatol. 2022;12(1):155–173.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97.
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, van Mil SW, Oldenburg B, et al. Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta. 2010;1801(7):683–692.
   PubMed Web of Science ®Google Scholar
• Perino A. Metabolic messengers: sk bile acids. Nat Metab. 2022;4(4):416–423.
   PubMedGoogle Scholar
• Tilg H, Adolph TE, Dudek M, et al. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3(12):1596–1607.
   PubMedGoogle Scholar
• Kim SY, Kim HJ, Lim H, et al. Association between cholelithiasis and sialolithiasis: two longitudinal follow-up studies. Medicine (Baltimore). 2019;98(25):e16153.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Ali A. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? Scand J Gastroenterol. 2014;49(5):521–527.
   PubMed Web of Science ®Google Scholar
• Colak Y, Bozbey G, Senates E, et al. Evaluation of gallbladder kinetics in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58(4):476A–477A.
   Google Scholar
• Smirnova E, Muthiah MD, Narayan N, et al. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD. Hepatology. 2022;76(6):1811–1824.
   PubMed Web of Science ®Google Scholar
• Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024.
   PubMed Web of Science ®Google Scholar
• Sbeit W, Sbeit M, Kalisky I, et al. The possible association of non-alcoholic fatty liver disease with acute cholangitis: a retrospective multicenter cohort study. Life (Basel). 2021;12(1):35.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wu N, Wang X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096.
   PubMed Web of Science ®Google Scholar
• Hu H, Shao W, Liu Q, et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun. 2022;13(1):252.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Boeltz S, Bilyy R, et al. Neutrophil extracellular traps initiate gallstone formation. Immunity. 2019;51(3):443–450 e4.
   PubMed Web of Science ®Google Scholar
• Kurt Z, Barrere-Cain R, LaGuardia J, et al. Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease. Biol Sex Differ. 2018;9(1):46.
   PubMedGoogle Scholar
• Wang S, Wang Y, Xu J, et al. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(14):e6556.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu Y, Wang L, et al. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J Lipid Res. 2013 Feb;54(2):345–357.
   PubMed Web of Science ®Google Scholar
• Dincer M, Dogan F. The effect of concomitant cholecystectomy and sleeve gastrectomy on morbidity in high-risk obese patients with symptomatic gallstones. Wideochir Inne Tech Maloinwazyjne. 2019;14(2):237–241.
   PubMedGoogle Scholar
• Yu AH, Duan-Mu YY, Zhang Y, et al. Correlation between non-alcoholic fatty liver disease and visceral adipose tissue in non-obese chinese adults: a CT evaluation. Korean J Radiol. 2018;19(5):923–929.
   PubMed Web of Science ®Google Scholar
• Yue W, Sun X, Du T. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. BMC Endocr Disord. 2019;19(1):95.
   PubMed Web of Science ®Google Scholar
• Mori S, Shiraishi A, Epplen K, et al. Characterization of skin function associated with obesity and specific correlation to local/systemic parameters in American women. Lipids Health Dis. 2017;16(1):214.
   PubMedGoogle Scholar
• Wang W, Zhong M, Yu T, et al. Polysaccharide extracted from WuGuChong reduces high-fat diet-induced obesity in mice by regulating the composition of intestinal microbiota. Nutr Metab (Lond). 2020;17:27.
   PubMed Web of Science ®Google Scholar
• Xue M, Liang H, Ji X, et al. Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology. Nutr Metab (Lond). 2019;16:87.
   PubMed Web of Science ®Google Scholar
• Kim YK, Kwon OS, Her KH. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: an observational Study. Medicine (Baltimore). 2019;98(27):e16018.
   PubMed Web of Science ®Google Scholar
• Qi L, Dai W, Kong J, et al. Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation. J Physiol Biochem. 2021;77(4):497–510.
   PubMed Web of Science ®Google Scholar
• Kwon Y, Jeong SJ. Relative skeletal muscle mass is an important factor in non-alcoholic fatty liver disease in non-obese children and adolescents. J Clin Med. 2020 Oct 19;9(10):3355.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li H, Zheng Y, et al. Association of lipoprotein-associated phospholipase A2 with the prevalence of nonalcoholic fatty liver disease: a result from the APAC study. Sci Rep. 2018;8(1):10127.
   PubMedGoogle Scholar
• Koller T, Kollerova J, Hlavaty T, et al. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012;47(2):197–203.
   PubMed Web of Science ®Google Scholar
• Fracanzani AL, Valenti L, Russello M, et al. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One. 2012;7(7):e41183.
   PubMed Web of Science ®Google Scholar
• Hajong R, Dhal MR, Naku N, et al. Incidence of nonalcoholic fatty liver disease in patients undergoing laparoscopic cholecystectomy. J Family Med Prim Care. 2018;7(6):1375–1378.
   PubMedGoogle Scholar
• Jang DK, Lee JS, Lee JK, et al. Independent association of physical activity with nonalcoholic fatty liver disease and alanine aminotransferase levels. J Clin Med. 2019;8(7):1013.
   PubMed Web of Science ®Google Scholar
• Kwak MS, Kim D. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. Korean J Intern Med. 2018;33(1):64–74.
   PubMed Web of Science ®Google Scholar